Igene Biotechnology Inc. (IGNE) Financials Nov 14,
Post# of 250675
Posted On: 11/17/2014 1:22:25 AM
Igene Biotechnology Inc. (IGNE) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Igene Biotechnology Inc.
Fiscal year is January-December. All values USD millions. 2006 2007 2008 2009 5-year trend
Sales/Revenue - 0 2.29M 7.64M 3.96M
Cost of Goods Sold (COGS) incl. D&A - 16,488 1.68M 6.4M 2.94M
COGS excluding D&A - 0 1.67M 6.02M 2.76M
Depreciation & Amortization Expense - 16,488 12,438 372,275 181,518
Depreciation - 16,488 12,438 107,821 150,723
Amortization of Intangibles - 0 0 264,454 30,795
Gross Income - (16,488) 605,098 1.25M 1.02M
2006 2007 2008 2009 5-year trend
SG&A Expense - 1.95M 2.11M 3.44M 3.08M
Research & Development - 847,598 983,610 1.66M 1.85M
Other SG&A - 1.1M 1.13M 1.78M 1.23M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 0 (1.03M)
EBIT after Unusual Expense - 0 0 0 1.03M
Non Operating Income/Expense - 1.68M 1.6M 225,813 2.09M
Non-Operating Interest Income - 77,982 50,581 0 0
Equity in Affiliates (Pretax) - (109,147) 170,821 0 (1.09M)
Interest Expense - 831,773 2.21M 2.03M 97,520
Gross Interest Expense - 831,773 2.21M 2.03M 97,520
Interest Capitalized - 0 0 0 0
Pretax Income - (1.16M) (1.9M) (3.99M) (140,747)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 0 0
Income Tax - Current Foreign - 0 0 0 0
Income Tax - Deferred Domestic - 0 0 0 0
Income Tax - Deferred Foreign - 0 0 0 0
Income Tax Credits - 0 0 0 0
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - - - - 0
Consolidated Net Income - (1.16M) (1.9M) (3.99M) (140,747)
Minority Interest Expense - 0 0 0 0
Net Income - (1.16M) (1.9M) (3.99M) (140,747)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (1.16M) (1.9M) (3.99M) (140,747)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (1.16M) (1.9M) (3.99M) (140,747)
EPS (Basic) - (0.01) (0.02) (0.02) 0.00
Basic Shares Outstanding - 103.38M 109.68M 187.04M 1.54B
EPS (Diluted) - (0.01) (0.02) (0.02) 0.00
Diluted Shares Outstanding - 103.38M 109.68M 187.04M 1.54B
EBITDA - (1.95M) (1.5M) (1.82M) (1.88M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Igene Biotechnology Inc.
Fiscal year is January-December. All values USD millions. 2006 2007 2008 2009 5-year trend
Sales/Revenue - 0 2.29M 7.64M 3.96M
Cost of Goods Sold (COGS) incl. D&A - 16,488 1.68M 6.4M 2.94M
COGS excluding D&A - 0 1.67M 6.02M 2.76M
Depreciation & Amortization Expense - 16,488 12,438 372,275 181,518
Depreciation - 16,488 12,438 107,821 150,723
Amortization of Intangibles - 0 0 264,454 30,795
Gross Income - (16,488) 605,098 1.25M 1.02M
2006 2007 2008 2009 5-year trend
SG&A Expense - 1.95M 2.11M 3.44M 3.08M
Research & Development - 847,598 983,610 1.66M 1.85M
Other SG&A - 1.1M 1.13M 1.78M 1.23M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 0 (1.03M)
EBIT after Unusual Expense - 0 0 0 1.03M
Non Operating Income/Expense - 1.68M 1.6M 225,813 2.09M
Non-Operating Interest Income - 77,982 50,581 0 0
Equity in Affiliates (Pretax) - (109,147) 170,821 0 (1.09M)
Interest Expense - 831,773 2.21M 2.03M 97,520
Gross Interest Expense - 831,773 2.21M 2.03M 97,520
Interest Capitalized - 0 0 0 0
Pretax Income - (1.16M) (1.9M) (3.99M) (140,747)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 0 0
Income Tax - Current Foreign - 0 0 0 0
Income Tax - Deferred Domestic - 0 0 0 0
Income Tax - Deferred Foreign - 0 0 0 0
Income Tax Credits - 0 0 0 0
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - - - - 0
Consolidated Net Income - (1.16M) (1.9M) (3.99M) (140,747)
Minority Interest Expense - 0 0 0 0
Net Income - (1.16M) (1.9M) (3.99M) (140,747)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (1.16M) (1.9M) (3.99M) (140,747)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (1.16M) (1.9M) (3.99M) (140,747)
EPS (Basic) - (0.01) (0.02) (0.02) 0.00
Basic Shares Outstanding - 103.38M 109.68M 187.04M 1.54B
EPS (Diluted) - (0.01) (0.02) (0.02) 0.00
Diluted Shares Outstanding - 103.38M 109.68M 187.04M 1.54B
EBITDA - (1.95M) (1.5M) (1.82M) (1.88M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)